the entire directory only in Pharmaceuticals/Cancer

See also:

• Health: Conditions and Diseases: Cancer: Centers: Research (26)
• Science: Biology: Genetics: Eukaryotic: Animal: Cancer (12)

• AC Immune SA. - Focus on CNS conformational diseases and oncology, using a combination of antibodies produced to non-covalent complexes of peptide sequences, presented as liposomes. Technical and corporate overviews of company in Lausanne, Switzerland.
• Allos Therapeutics, Inc. - Develops and commercializes innovative small molecule drugs, initially for improving cancer treatments. Based in Westminster, Colorado. (Nasdaq: ALTH)
• Amynon Biotech GmbH. - Develops compounds for the diagnosis of viral and non-viral induced tumour-related diseases in Innsbruck, Austria.
• Aventis Cancer Vaccine Program - Studying the possibilities of using an immunotherapeutic approach for melanoma, breast and colorectal and tumors. Includes results of clinical research, FAQ, contact form, and profile of research partners in Canada.
• Biomira Inc. - Develops organic chemistry and immunotherapy technology to produce synthetic therapeutic vaccines targeting proliferative tumors. Resources for patients and professionals and investors, with profile of company based in Edmonton, Alberta. (Nasdaq: BIOM)
• Biotica - Company focused on the discovery and development of anti-cancer drugs through synthetic biology of natural polyketides and rapamycin analogues. Describes technology, pipeline, and facilities near Saffron Walden, England.
• Boston Life Sciences, Inc. - Researches and develops novel therapeutic and diagnostic products to treat chronic debilitating diseases such as cancer, central nervous system disorders and autoimmune diseases. Based in Massachusetts. (Nasdaq: BLSI).
• Cancer Survival Toolbox - Introduction the mechanisms, with resources in oncology, vascular medicine and immunolgical disease, including possible therapies and links to related organizations, presented by Genentech, Inc.
• Crusade Laboratories Ltd. - Start-up focusing on the discovery, development and commercialisation of novel treatments for tumors and neurodegenerative diseases. Includes investor information, technology in GM-HSV targeting glioma and clinical trials in Glasgow, UK.
• Micromet, Inc. - Development and commercialization of vaccines, and treatments, such as telomere homologs and angiogenesis inhibition. Includes product pipeline, clinical trials, corporate profile and contacts in Carlsbad, California.
• Oncogene Science - Diagnostic and therapeutic products relating to prostate specific antigen and oncoproteins, within a division of Bayer in Cambridge, Massachusetts
• Onyvax Ltd. - Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells. Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their contacts in London, UK.
• PNP Therapeutics, Inc. - Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama.
• Pivotal BioSciences, Inc. - Management and pipeline of cancer therapeutics licensed from the University of Southern California Keck School of Medicine in Los Angeles, California.
• Topotarget - Oncology studies in small molecule histone deacetylase and topoisomerase II inhibitors, with clinical trials in solid tumours, CNS and extravasation. Technology and profile of company with facilities in Copenhagen and Abingdon, England.

"Cancer" search on:   AOL - Ask - Bing - Gigablast - Google - Lycos - Yahoo - Yippy

Volunteer to edit this category.

Copyright © 2012 Netscape Terms of Use